Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 127 participants.
Also called NCT05536271
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 127 participants
- Registry
-
NCT05536271
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT05536271. Allocation not applicable; no masking; primary purpose treatment. Start 2021-09-01 (actual); primary completion 2022-06-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Bisoprolol Fumarate
- Lead sponsor
- Damanhour University
- Collaborator
- Alexandria University
Record details
- Record id
cardio:ct-nct05536271- Content hash
d6280ae4b9071dca8ff8a82f8c98b9b3791f40e1978035e474dd85c993a1c597